ALPS ADVISORS INC

Position in MGNX — Macrogenics Inc

CIK 1376113 Denver, CO

Position in MGNX

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$298,026

+$236,246 QoQ

Shares Held

64,508

+32.6% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 122 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. MGNX ranks #104 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	315,335	$17,680,833
2	APGE	Apogee Therapeutics, Inc.	62,523	$8,298,677
3	CGON	CG Oncology, Inc.	89,218	$6,338,938
4	XENE	Xenon Pharmaceuticals Inc.	97,610	$5,891,739
5	ORKA	Oruka Therapeutics, Inc.	61,014	$5,806,702
6	DNTH	Dianthus Therapeutics, Inc. /DE/	55,281	$5,388,791
7	TVTX	Travere Therapeutics, Inc.	93,981	$5,339,060
8	DFTX	Definium Therapeutics, Inc.	110,388	$5,192,651

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$298,026	64,508	+32.6%	Shares	Defined	2026-07-29
2025-03-31	$61,780	48,646	-4.1%	Shares	Defined	2025-04-30
2024-12-31	$164,937	50,750	+16.0%	Shares	Defined	2025-02-13
2024-03-31	$644,029	43,752	+5.0%	Shares	Defined	2024-05-14
2023-12-31	$400,903	41,674	-8.8%	Shares	Defined	2024-02-14
2023-09-30	$212,934	45,694	+0.5%	Shares	Defined	2023-11-14
2023-06-30	$243,173	45,453	-27.9%	Shares	Defined	2023-08-14
2022-03-31	$555,241	63,024	-11.1%	Shares	Defined	2022-05-16
2021-12-31	$1,137,768	70,889	-5.4%	Shares	Defined	2022-02-09
2021-09-30	$1,568,343	74,897	-5.3%	Shares	Defined	2021-11-15
2021-06-30	$2,124,008	79,077	-11.1%	Shares	Defined	2021-08-11
2020-03-31	$517,572	88,930	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.